North America Orthobiologics Market Size (Value, Volume, ASP) by Segments (Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others), Share and Forecast, 2015-2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: February 26, 2021 Report Code: GDMECR1597DB-ST

Select Item

GlobalData’s “North America Orthobiologics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair, Soft Tissue Biologics and Viscosupplementation.

The North America Orthobiologics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Orthobiologics Market.
• Global corporate-level profiles of key companies operating within the North America Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Orthobiologics is segmented as follows:

• Bone Grafts and Substitutes

• Bone Growth Stimulators

• Cartilage Repair

• Soft Tissue Biologics

• Viscosupplementation

Reasons to Buy

Key Reasons to Purchase – The North America Orthobiologics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Orthobiologics Market Outlook to 2025” report:
• DePuy Synthes Inc
• Stryker Corp
• Smith & Nephew Plc

Table of Contents

1 Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Orthobiologics Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Orthobiologics Market, North America 14

3.1 Orthobiologics Market, North America, Revenue ($m), 2015-2025 14

3.2 Orthobiologics Market, North America, Revenue ($m), 2015-2025 15

3.3 Orthobiologics Market, North America, Volume (Units), 2015-2025 18

3.4 Orthobiologics Market, North America, Volume (Units), 2015-2025 19

3.5 Orthobiologics Market, North America, Company Share by Revenue ($m), 2019 22

4 Orthobiologics Market, Canada 24

4.1 Orthobiologics Market, Canada, Revenue ($m), 2015-2025 24

4.1.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2015-2025 27

4.1.2 Bone Growth Stimulators Market, Canada, Revenue ($m), by Segment, 2015-2025 29

4.1.3 Cartilage Repair Market, Canada, Revenue ($m), by Segment, 2015-2025 31

4.1.4 Soft Tissue Biologics Market, Canada, Revenue ($m), by Segment, 2015-2025 33

4.1.5 Viscosupplementation Market, Canada, Revenue ($m), by Segment, 2015-2025 35

4.2 Orthobiologics Market, Canada, Volume (Units), 2015-2025 37

4.2.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2015-2025 40

4.2.2 Bone Growth Stimulators Market, Canada, Volume (Units), by Segment, 2015-2025 42

4.2.3 Cartilage Repair Market, Canada, Volume (Units), by Segment, 2015-2025 44

4.2.4 Soft Tissue Biologics Market, Canada, Volume (Units), by Segment, 2015-2025 46

4.2.5 Viscosupplementation Market, Canada, Volume (Units), by Segment, 2015-2025 48

4.3 Orthobiologics Market, Canada, Average Price ($), 2015-2025 50

4.4 Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2019 54

4.5 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2019 55

5 Orthobiologics Market, Mexico 57

5.1 Orthobiologics Market, Mexico, Revenue ($m), 2015-2025 57

5.1.1 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2015-2025 60

5.1.2 Bone Growth Stimulators Market, Mexico, Revenue ($m), by Segment, 2015-2025 62

5.1.3 Cartilage Repair Market, Mexico, Revenue ($m), by Segment, 2015-2025 64

5.1.4 Soft Tissue Biologics Market, Mexico, Revenue ($m), by Segment, 2015-2025 66

5.1.5 Viscosupplementation Market, Mexico, Revenue ($m), by Segment, 2015-2025 68

5.2 Orthobiologics Market, Mexico, Volume (Units), 2015-2025 70

5.2.1 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2015-2025 73

5.2.2 Bone Growth Stimulators Market, Mexico, Volume (Units), by Segment, 2015-2025 75

5.2.3 Cartilage Repair Market, Mexico, Volume (Units), by Segment, 2015-2025 77

5.2.4 Soft Tissue Biologics Market, Mexico, Volume (Units), by Segment, 2015-2025 79

5.2.5 Viscosupplementation Market, Mexico, Volume (Units), by Segment, 2015-2025 81

5.3 Orthobiologics Market, Mexico, Average Price ($), 2015-2025 83

5.4 Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), 2019 87

5.5 Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2019 88

6 Orthobiologics Market, United States 90

6.1 Orthobiologics Market, United States, Revenue ($m), 2015-2025 90

6.1.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 93

6.1.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2015-2025 96

6.1.3 Cartilage Repair Market, United States, Revenue ($m), by Segment, 2015-2025 98

6.1.4 Soft Tissue Biologics Market, United States, Revenue ($m), by Segment, 2015-2025 100

6.1.5 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2015-2025 102

6.2 Orthobiologics Market, United States, Volume (Units), 2015-2025 104

6.2.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 107

6.2.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2015-2025 110

6.2.3 Cartilage Repair Market, United States, Volume (Units), by Segment, 2015-2025 112

6.2.4 Soft Tissue Biologics Market, United States, Volume (Units), by Segment, 2015-2025 114

6.2.5 Viscosupplementation Market, United States, Volume (Units), by Segment, 2015-2025 116

6.3 Orthobiologics Market, United States, Average Price ($) , 2015-2025 118

6.4 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2019 122

6.5 Orthobiologics Market, United States, Company Share by Revenue ($m), 2019 123

7 Overview of Key Companies in North America Orthobiologics Market 125

7.1 DePuy Synthes Inc 125

7.1.1 Company Overview 125

7.2 Stryker Corp 125

7.2.1 Company Overview 125

7.3 Smith & Nephew Plc 125

7.3.1 Company Overview 125

7.4 Medtronic Plc 126

7.4.1 Company Overview 126

7.5 Zimmer Biomet Holdings Inc 126

7.5.1 Company Overview 126

7.6 B. Braun Melsungen AG 126

7.6.1 Company Overview 126

7.7 Sanofi 126

7.7.1 Company Overview 126

7.8 Bioventus LLC 127

7.8.1 Company Overview 127

7.9 ConMed Corp 127

7.9.1 Company Overview 127

7.10 Ferring Pharmaceuticals AS 127

7.10.1 Company Overview 127

7.11 Arthrex Inc 127

7.11.1 Company Overview 127

7.12 Seikagaku Corp 128

7.12.1 Company Overview 128

7.13 Fidia farmaceutici SpA 128

7.13.1 Company Overview 128

7.14 SeaSpine, Inc. 128

7.14.1 Company Overview 128

7.15 Anika Therapeutics Inc 128

7.15.1 Company Overview 128

7.16 Orthofix Holdings Inc 129

7.16.1 Company Overview 129

8 Orthobiologics Market Pipeline Products 130

9 Recent Developments 138

9.1 Corporate Communications 138

9.1.1 Jan 13, 2021: MTF Biologics awards over $1 Million in 2020 Extramural Research Grants and announces timeline for 2021 applications 138

9.1.2 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 139

9.1.3 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 140

9.2 Financial Announcements 140

9.2.1 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 140

9.2.2 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA 143

9.2.3 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 145

9.2.4 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results 146

9.2.5 Jan 29, 2020: Current Health collaborates with Mass General Hospital to reduce maternal mortality rates in Sub-Saharan Africa 147

9.2.6 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 148

9.2.7 Jan 24, 2020: The first patient included in Australia in Isofol's phase 3 AGENT study 149

9.3 Legal And Regulatory 149

9.3.1 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures 149

9.4 Other Significant Developments 150

9.4.1 Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device 150

9.4.2 Jul 07, 2020: New collagen supply agreement with NovaBone Products 150

9.4.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 151

9.4.4 May 28, 2020: Conformis announces settlement of patent dispute 151

9.4.5 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 151

9.4.6 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 152

9.4.7 Feb 12, 2020: Regenexx, first to use stem cells in orthopedic therapy, marks 15th anniversary 153

9.5 Product News 154

9.5.1 Nov 04, 2020: WFIRM scientists create hybrid tissue construct for cartilage regeneration 154

9.6 Strategy And Business Planning 155

9.6.1 Jun 26, 2020: Valet Health & DataBiologics combined solution support of data-driven physicians offering orthobiologics treatments 155

9.6.2 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis 156

9.6.3 Feb 18, 2020: Georgia Bone & Joint Partners With AMP Recover To Service Self-Funded Employer Market 157

10 Appendix 158

10.1 Research Methodology 159

10.1.1 Coverage 159

10.1.2 Secondary Research 159

10.1.3 Primary Research 160

10.1.4 Market Modeling and Forecasting 161

10.1.5 Company Share Analysis 162

10.1.6 Distribution Share Analysis 162

10.1.7 Benchmarking 163

10.2 GlobalData Consulting 163

10.3 Contact Us 164

10.4 Disclaimer 164

Table

1.1 List of Tables

Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 14

Table 2: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 16

Table 3: Orthobiologics Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 17

Table 4: Orthobiologics Market, North America, Volume (Units), 2015-2025 18

Table 5: Orthobiologics Market, North America, Volume (Units), 2015-2020 20

Table 6: Orthobiologics Market, North America, Volume (Units), 2021-2025 21

Table 7: Orthobiologics Market, North America, Company Share by Revenue ($m), USD Constant, 2019 23

Table 8: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2015-2020 25

Table 9: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2021-2025 26

Table 10: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2020 28

Table 11: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2021-2025 28

Table 12: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2015-2020 30

Table 13: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2021-2025 30

Table 14: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2015-2020 32

Table 15: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2021-2025 32

Table 16: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2015-2020 34

Table 17: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2021-2025 34

Table 18: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2015-2020 36

Table 19: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2021-2025 36

Table 20: Orthobiologics Market, Canada, Volume (Units), 2015-2020 38

Table 21: Orthobiologics Market, Canada, Volume (Units), 2021-2025 39

Table 22: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2015-2020 41

Table 23: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2021-2025 41

Table 24: Bone Growth Stimulators Market, Canada, Volume (Units), 2015-2020 43

Table 25: Bone Growth Stimulators Market, Canada, Volume (Units), 2021-2025 43

Table 26: Cartilage Repair Market, Canada, Volume (Units), 2015-2020 45

Table 27: Cartilage Repair Market, Canada, Volume (Units), 2021-2025 45

Table 28: Soft Tissue Biologics Market, Canada, Volume (Units), 2015-2020 47

Table 29: Soft Tissue Biologics Market, Canada, Volume (Units), 2021-2025 47

Table 30: Viscosupplementation Market, Canada, Volume (Units), 2015-2020 49

Table 31: Viscosupplementation Market, Canada, Volume (Units), 2021-2025 49

Table 32: Orthobiologics Market, Canada, Average Price ($), 2015-2020 50

Table 33: Orthobiologics Market, Canada, Average Price ($), 2021-2025 52

Table 34: Orthobiologics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2019 54

Table 35: Orthobiologics Market, Canada, Company Share by Revenue ($m), USD Constant, 2019 56

Table 36: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2015-2020 58

Table 37: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2021-2025 59

Table 38: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2020 61

Table 39: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2021-2025 61

Table 40: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2015-2020 63

Table 41: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2021-2025 63

Table 42: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2015-2020 65

Table 43: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2021-2025 65

Table 44: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2015-2020 67

Table 45: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2021-2025 67

Table 46: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2015-2020 69

Table 47: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2021-2025 69

Table 48: Orthobiologics Market, Mexico, Volume (Units), 2015-2020 71

Table 49: Orthobiologics Market, Mexico, Volume (Units), 2021-2025 72

Table 50: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2015-2020 74

Table 51: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2021-2025 74

Table 52: Bone Growth Stimulators Market, Mexico, Volume (Units), 2015-2020 76

Table 53: Bone Growth Stimulators Market, Mexico, Volume (Units), 2021-2025 76

Table 54: Cartilage Repair Market, Mexico, Volume (Units), 2015-2020 78

Table 55: Cartilage Repair Market, Mexico, Volume (Units), 2021-2025 78

Table 56: Soft Tissue Biologics Market, Mexico, Volume (Units), 2015-2020 80

Table 57: Soft Tissue Biologics Market, Mexico, Volume (Units), 2021-2025 80

Table 58: Viscosupplementation Market, Mexico, Volume (Units), 2015-2020 82

Table 59: Viscosupplementation Market, Mexico, Volume (Units), 2021-2025 82

Table 60: Orthobiologics Market, Mexico, Average Price ($), 2015-2020 83

Table 61: Orthobiologics Market, Mexico, Average Price ($), 2021-2025 85

Table 62: Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2019 87

Table 63: Orthobiologics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2019 89

Table 64: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2020 91

Table 65: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2021-2025 92

Table 66: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 94

Table 67: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 95

Table 68: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2020 97

Table 69: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2021-2025 97

Table 70: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2015-2020 99

Table 71: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2021-2025 99

Table 72: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2020 101

Table 73: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2021-2025 101

Table 74: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2020 103

Table 75: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2021-2025 103

Table 76: Orthobiologics Market, United States, Volume (Units), 2015-2020 105

Table 77: Orthobiologics Market, United States, Volume (Units), 2021-2025 106

Table 78: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2020 108

Table 79: Bone Grafts and Substitutes Market, United States, Volume (Units), 2021-2025 109

Table 80: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2020 111

Table 81: Bone Growth Stimulators Market, United States, Volume (Units), 2021-2025 111

Table 82: Cartilage Repair Market, United States, Volume (Units), 2015-2020 113

Table 83: Cartilage Repair Market, United States, Volume (Units), 2021-2025 113

Table 84: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2020 115

Table 85: Soft Tissue Biologics Market, United States, Volume (Units), 2021-2025 115

Table 86: Viscosupplementation Market, United States, Volume (Units), 2015-2020 117

Table 87: Viscosupplementation Market, United States, Volume (Units), 2021-2025 117

Table 88: Orthobiologics Market, United States, Average Price ($), 2015-2020 118

Table 89: Orthobiologics Market, United States, Average Price ($), 2021-2025 120

Table 90: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 122

Table 91: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2019 124

Table 92: Orthobiologics Market Pipeline Products 130

Table 93: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 161

Figures

1.2 List of Figures

Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 14

Figure 2: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 15

Figure 3: Orthobiologics Market, North America, Volume (Units), 2015-2025 18

Figure 4: Orthobiologics Market, North America, Volume (Units), 2015-2025 19

Figure 5: Orthobiologics Market, North America, Company Share (%) 2019 22

Figure 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2015-2025 24

Figure 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025 27

Figure 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2015-2025 29

Figure 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2015-2025 31

Figure 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2015-2025 33

Figure 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2015-2025 35

Figure 12: Orthobiologics Market, Canada, Volume (Units), 2015-2025 37

Figure 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2015-2025 40

Figure 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2015-2025 42

Figure 15: Cartilage Repair Market, Canada, Volume (Units), 2015-2025 44

Figure 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2015-2025 46

Figure 17: Viscosupplementation Market, Canada, Volume (Units), 2015-2025 48

Figure 18: Orthobiologics Market, Canada, Company Share (%) 2019 55

Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2015-2025 57

Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2025 60

Figure 21: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2015-2025 62

Figure 22: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2015-2025 64

Figure 23: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2015-2025 66

Figure 24: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2015-2025 68

Figure 25: Orthobiologics Market, Mexico, Volume (Units), 2015-2025 70

Figure 26: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2015-2025 73

Figure 27: Bone Growth Stimulators Market, Mexico, Volume (Units), 2015-2025 75

Figure 28: Cartilage Repair Market, Mexico, Volume (Units), 2015-2025 77

Figure 29: Soft Tissue Biologics Market, Mexico, Volume (Units), 2015-2025 79

Figure 30: Viscosupplementation Market, Mexico, Volume (Units), 2015-2025 81

Figure 31: Orthobiologics Market, Mexico, Company Share (%) 2019 88

Figure 32: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2025 90

Figure 33: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 93

Figure 34: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2025 96

Figure 35: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2015-2025 98

Figure 36: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2025 100

Figure 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2025 102

Figure 38: Orthobiologics Market, United States, Volume (Units), 2015-2025 104

Figure 39: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2025 107

Figure 40: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2025 110

Figure 41: Cartilage Repair Market, United States, Volume (Units), 2015-2025 112

Figure 42: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2025 114

Figure 43: Viscosupplementation Market, United States, Volume (Units), 2015-2025 116

Figure 44: Orthobiologics Market, United States, Company Share (%) 2019 123

Frequently asked questions

North America Orthobiologics Market Size (Value, Volume, ASP) by Segments (Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others), Share and Forecast, 2015-2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthopedic Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Orthobiologics Market Size (Value, Volume, ASP) by Segments (Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others), Share and Forecast, 2015-2025 in real time.

  • Access a live North America Orthobiologics Market Size (Value, Volume, ASP) by Segments (Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others), Share and Forecast, 2015-2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more